You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Myeloproliferative Neoplasm

Showing 1 - 25 of 899
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Myeloproliferative Tumor, Polycythemia Vera, Essential Thrombocythemia Trial in Hong Kong

Recruiting
  • Myeloproliferative Neoplasm
  • +7 more
    • Hong Kong, Hong Kong
      Department of Medicine, Queen Mary Hospital
    May 21, 2023

    Myeloproliferative Tumor, Secondary Leukemia Trial (Multiomic characterization, In vitro drug screening)

    Not yet recruiting
    • Myeloproliferative Neoplasm
    • Secondary Leukemia
    • Multiomic characterization
    • In vitro drug screening
    • (no location specified)
    Aug 28, 2023

    Epidemiological and Clinical-pathological Factors of

    Completed
    • Myeloproliferative Neoplasm
    • +4 more
      • Guayaquil, Guayas, Ecuador
        Sociedad de Lucha Contra el Cáncer
      Apr 25, 2023

      Myeloproliferative Disorders, Leukemia Trial in Boston (Cardiac Lifestyle Program)

      Not yet recruiting
      • Myeloproliferative Disorders
      • Leukemia
      • Cardiac Lifestyle Program
      • Boston, Massachusetts
      • +2 more
      May 1, 2023

      Myelodysplastic/Myeloproliferative Tumor, Steroid Refractory GVHD, Allogeneic Hematopoietic Cell Transplant Trial in Toronto

      Completed
      • Myelodysplastic/Myeloproliferative Neoplasm
      • +2 more
      • Decidual stromal cells (DSC)
      • Toronto, Ontario, Canada
        Princess Margaret Cancer Centre
      Jan 8, 2023

      Epigenetic Age on Clinic-biological Presentation and Prognosis

      Not yet recruiting
      • Myeloproliferative Neoplasm
      • Assessment of the epigenetic age
      • Bordeaux, France
        CHU de Bordeaux, service Hématologie Biologique
      Aug 28, 2023

      Carotid Plaque Burden in Philadelphia Negative

      Recruiting
      • Myeloproliferative Neoplasm
        • Sohag, Egypt
          Faculty of Medicine
        Aug 14, 2023

        Acute Myeloid Leukemia, Leukemia, Leukemia, Myeloid Trial in Boston (Cytokine Induced Memory-like Natural Killer Cells,

        Not yet recruiting
        • Acute Myeloid Leukemia
        • +5 more
        • Cytokine Induced Memory-like Natural Killer Cells
        • Interleukin-2
        • Boston, Massachusetts
        • +1 more
        Nov 14, 2023

        Accelerated Phase MPN, Blast Phase MPN Trial (zelavespib)

        Withdrawn
        • Accelerated Phase MPN
        • Blast Phase MPN
        • (no location specified)
        Nov 4, 2022

        Action of Interferon in Treatment of Myeloproliferative

        Recruiting
        • Myeloproliferative Neoplasm
          • Villejuif, Ile De France, France
            Inserm U1287
          Apr 28, 2023

          Myelodysplastic/Myeloproliferative Tumor, Unclassifiable, Myelofibrosis Transformation in Essential Thrombocythemia,

          Recruiting
          • Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable
          • +3 more
          • Houston, Texas
            M D Anderson Cancer Center
          Aug 18, 2022

          Myelodysplastic/Myeloproliferative Tumor With Ring Sideroblasts and Thrombocytosis, Myelodysplastic/Myeloproliferative Tumor,

          Recruiting
          • Myelodysplastic/Myeloproliferative Neoplasm With Ring Sideroblasts and Thrombocytosis
          • Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable
          • Rochester, Minnesota
            Mayo Clinic in Rochester
          Jan 6, 2023

          Myeloproliferative Tumor Trial in Irvine (Diet intervention)

          Completed
          • Myeloproliferative Neoplasm
          • Diet intervention
          • Irvine, California
            University of California, Irvine
          Jun 16, 2022

          Myeloproliferative Tumor Trial in Tampa (Fedratinib Pill)

          Recruiting
          • Myeloproliferative Neoplasm
          • Fedratinib Pill
          • Tampa, Florida
            Moffitt Cancer Center
          Nov 28, 2022

          Myeloproliferative Tumor, MPN, Essential Thrombocythemia Trial in Orange (N-Acetylcysteine)

          Active, not recruiting
          • Myeloproliferative Neoplasm
          • +4 more
          • Orange, California
            Chao Family Comprehensive Cancer Center, University of Californi
          Jan 6, 2023

          Myeloid Malignancy, Acute Myeloid Leukemia, MDS Trial in Rochester (Telehealth Serious Illness Care Program, Education Control)

          Not yet recruiting
          • Myeloid Malignancy
          • +4 more
          • Telehealth Serious Illness Care Program
          • Education Control
          • Rochester, New York
            University of Rochester
          May 24, 2023

          Bone Marrow Fibrosis, Myeloproliferative Tumor Trial in Cleveland (Captopril)

          Not yet recruiting
          • Bone Marrow Fibrosis
          • Myeloproliferative Neoplasm
          • Cleveland, Ohio
            Cleveland Clinic, Case Comprehensive Cancer Center
          Jan 30, 2023

          Myeloproliferative Tumor, Optical Genome Mapping, Cytogenetics Trial in Amiens (Blood sample)

          Recruiting
          • Myeloproliferative Neoplasm
          • +4 more
          • Blood sample
          • Amiens, Picardie, France
            Centre Hospitalier Universitaire d'Amiens
          Jan 27, 2023

          Acute Myeloid Leukemia, Essential Thrombocythemia, Myelodysplastic Syndrome Trial in Seattle (Decitabine, Ruxolitinib,

          Recruiting
          • Acute Myeloid Leukemia
          • +8 more
          • Seattle, Washington
            Fred Hutch/University of Washington Cancer Consortium
          Aug 18, 2022

          Chronic Myelomonocytic Leukemia, Myelodysplastic Syndrome, Myeloproliferative Tumor Trial in Houston (Azacitidine, Quizartinib)

          Recruiting
          • Chronic Myelomonocytic Leukemia
          • +5 more
          • Houston, Texas
            M D Anderson Cancer Center
          May 23, 2022

          Myelofibrosis, Essential Thrombocythemia, MPN Trial in New York (Peptide-based vaccine, Poly ICLC)

          Not yet recruiting
          • Myelofibrosis
          • +2 more
          • Peptide-based vaccine
          • Poly ICLC
          • New York, New York
            Icahn School of Medicine at Mount Sinai
          Jun 7, 2022

          Monocytes Sub-populations in Thrombosis Associated With

          Recruiting
          • Myeloproliferative Neoplasm
          • 1 additional tube of blood
          • Bordeaux, France
          • +4 more
          Nov 30, 2022

          Chronic Myelomonocytic Leukemia, Myelodysplastic Syndrome, Myelodysplastic Syndrome With Excess Blasts Trial (Biospecimen

          Not yet recruiting
          • Chronic Myelomonocytic Leukemia
          • +3 more
          • Biospecimen Collection
          • +3 more
          • (no location specified)
          Oct 27, 2022

          MDS, Myeloproliferative Tumor, Anemia Trial in Tampa (Luspatercept)

          Recruiting
          • Myelodysplastic Syndromes
          • +2 more
          • Tampa, Florida
            Moffitt Cancer Center
          Feb 16, 2023

          Myeloproliferative Tumor, Essential Thrombocythemia, Primary Myelofibrosis, Prefibrotic Stage Trial (CALR allele burden

          Recruiting
          • Myeloproliferative Neoplasm
          • +3 more
          • CALR allele burden quantification
          • Angers, France
            CHU Angers
          Nov 2, 2022